Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a.
about
Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Immunometabolic profiling of p ...... tment with interferon beta-1a.
@en
type
label
Immunometabolic profiling of p ...... tment with interferon beta-1a.
@en
prefLabel
Immunometabolic profiling of p ...... tment with interferon beta-1a.
@en
P2093
P50
P1433
P1476
Immunometabolic profiling of p ...... atment with interferon beta-1a
@en
P2093
Alessandra Colamatteo
Anna De Rosa
Carla De Luca Picione
Dario Bruzzese
Fortunata Carbone
Francesco Saccà
Giuseppe Matarese
Roberta Lanzillo
Teresa Micillo
Veronica De Rosa
P304
P356
10.1016/J.CLIM.2017.08.011
P577
2017-08-18T00:00:00Z